Lipitor Pilot Study Shows Benefit In Alzheimer's Disease
This article was originally published in The Pink Sheet Daily
Executive Summary
One-year data presented at the American Heart Association's Scientific Sessions show added effect for Pfizer's statin in patients with mild to moderate Alzheimer's receiving cholinesterase inhibitors.
You may also be interested in...
Lilly Gains Rights To Applied NeuroSolutions' Alzheimer's Research
Research includes expertise in the neuropathology of Alzheimer's as it relates to formation of neurofibrillary tangles.
Madrigal’s FDA Approval In MASH Ends Years Of Industry Frustration
As the first approved MASH (formerly NASH) therapy, nearly four years after initially anticipated, Madrigal gets the opportunity to establish a MASH marketplace with Rezdiffra (resmetirom).